Publication | Closed Access

TRA-418, a novel compound having both thromboxane A2 receptor antagonistic and prostaglandin I2 receptor agonistic activities: its antiplatelet effects in human and animal platelets

ThrombopoiesisThrombosisBlood PlateletPharmacologyHematologyHemostasisNovel CompoundPlatelet AntagonistPharmacotherapyAnimal PlateletsAntiplatelet EffectsMedicineAnticoagulantDrug Discovery